Equatorial Guinea vs Guinea-Bissau: Immunization, Hib3
Equatorial Guinea
68.0%
in 2024
Guinea-Bissau
68.0%
in 2024
Equatorial Guinea rank
171st
Guinea-Bissau rank
171st
Immunization, Hib3 over time
- Equatorial Guinea
- Guinea-Bissau
How they compare
Equatorial Guinea currently reports 68.0% against 68.0% in Guinea-Bissau, a difference of 0.0%.
Across all 11 years both countries report, Guinea-Bissau has been ahead every year.
Equatorial Guinea ranks 171st and Guinea-Bissau ranks 171st of 191 countries.
Guinea-Bissau has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.8% | 82.7% | 28.8% | Guinea-Bissau |
| 2020s | 68.6% | 71.4% | 2.8% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Equatorial Guinea or Guinea-Bissau?
- Equatorial Guinea, at 68.0% against 68.0% in Guinea-Bissau as of 2024.
- What is the difference in immunization, hib3 between Equatorial Guinea and Guinea-Bissau?
- 0.0%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Guinea-Bissau?
- 11 years are reported by both, from 2014 to 2024.
- How do Equatorial Guinea and Guinea-Bissau rank globally for immunization, hib3?
- Equatorial Guinea ranks 171st and Guinea-Bissau ranks 171st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.